Ismail, Huda, et al. “Targeting the IL-33 ST2 Signalling Pathway As a Therapeutic Strategy for the Treatment of Multiple Inflammatory Diseases”. Pharmakeftiki , vol. 37, no. 2S, Oct. 2025, doi:10.60988/p.v37i2S.280.